CLE could be used to differentiate lesions when the previous diagnostic work-up, including MRI and laboratory results for pituitary hormone levels, serum angiotensin-converting enzyme levels (to identify sarcoidosis), or hCG levels (to identify a germinoma), does not provide sufficient evidence for a clear diagnosis. This evidence concerns the gene ACE and sarcoidosis.